{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:43:24Z","timestamp":1786236204002,"version":"build-2736575974"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008853","name":"Jining Medical University","doi-asserted-by":"publisher","award":["JYHL2022FZD03"],"award-info":[{"award-number":["JYHL2022FZD03"]}],"id":[{"id":"10.13039\/501100008853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024MH098"],"award-info":[{"award-number":["ZR2024MH098"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejphar.2026.179128","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:39:23Z","timestamp":1783600763000},"page":"179128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Research advances of colchicine in anti-inflammatory treatment for coronary artery disease"],"prefix":"10.1016","volume":"1030","author":[{"given":"Mengyu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuimei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1180-0305","authenticated-orcid":false,"given":"Xueying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179128_bib1","article-title":"Cholesterol crystals induce mechanical trauma, inflammation, and neo-vascularization in solid cancers as in atherosclerosis","volume":"35","author":"Abela","year":"2023","journal-title":"Am. Heart J.: Cardiol. Res. Pract."},{"key":"10.1016\/j.ejphar.2026.179128_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1345521","article-title":"The effect of colchicine on cholesterol crystal formation, expansion and morphology: a potential mechanism in atherosclerosis","volume":"11","author":"Abideen","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2026.179128_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13464","article-title":"Effect of low-dose colchicine in acute and chronic coronary syndromes: a systematic review and meta-analysis","volume":"51","author":"Aimo","year":"2021","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2026.179128_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.acvd.2016.10.004","article-title":"COLIN trial: value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response","volume":"110","author":"Akodad","year":"2017","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.ejphar.2026.179128_bib5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1186\/s12872-021-02393-9","article-title":"Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial","volume":"21","author":"Akrami","year":"2021","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ejphar.2026.179128_bib6","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.4244\/EIJ-D-21-01034","article-title":"Management of in-stent restenosis","volume":"18","author":"Alfonso","year":"2022","journal-title":"Eurointervention"},{"key":"10.1016\/j.ejphar.2026.179128_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2459\/JCM.0000000000001157","article-title":"Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trials","volume":"22","author":"Andreis","year":"2021","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2026.179128_bib8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612824666180123110042","article-title":"Colchicine pharmacokinetics and mechanism of action","volume":"24","author":"Angelidis","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2026.179128_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001887","article-title":"Colchicine for symptomatic coronary artery disease after percutaneous coronary intervention","volume":"9","author":"Aw","year":"2022","journal-title":"Open Heart"},{"key":"10.1016\/j.ejphar.2026.179128_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/FJC.0000000000001319","article-title":"Evaluating the utility of colchicine in acute coronary syndrome: a systematic review and meta-analysis","volume":"80","author":"Bao","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179128_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/HCV.0000000000000088","article-title":"2023 ACC\/AHA\/SCAI advanced training statement on interventional cardiology (coronary, peripheral vascular, and structural heart interventions): a report of the ACC competency management committee","volume":"16","author":"Bass","year":"2023","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ejphar.2026.179128_bib12","first-page":"531","article-title":"Colchicine antagonizes the activity of human smooth muscle cells cultivated from arteriosclerotic lesions after atherectomy","volume":"5","author":"Bauriedel","year":"1994","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.ejphar.2026.179128_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cjco.2022.01.003","article-title":"Cost-effectiveness of canakinumab from a canadian perspective for recurrent cardiovascular events","volume":"4","author":"Boczar","year":"2022","journal-title":"CJC Open"},{"key":"10.1016\/j.ejphar.2026.179128_bib14","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the colchicine cardiovascular outcomes trial (COLCOT)","volume":"41","author":"Bouabdallaoui","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2026.179128_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002474","article-title":"Colchicine in acute myocardial infarction: cardiovascular events at 1-year follow up","volume":"11","author":"Bouleti","year":"2024","journal-title":"Open Heart"},{"key":"10.1016\/j.ejphar.2026.179128_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ahj.2024.09.006","article-title":"Exploration of the regional effects of colchicine in the LoDoCo2 trial","volume":"278","author":"Budgeon","year":"2024","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2026.179128_bib17","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/eurjpc\/zwad221","article-title":"Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease","volume":"30","author":"Burger","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib18","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.7150\/ijbs.93544","article-title":"Colchicine blocks abdominal aortic aneurysm development by maintaining vascular smooth muscle cell homeostasis","volume":"20","author":"Chen","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2026.179128_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106822","article-title":"Colchicine inhibits the prothrombotic effects of oxLDL in human endothelial cells","volume":"137","author":"Cimmino","year":"2021","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179128_bib20","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3390\/ijms24032483","article-title":"Colchicine in athero-thrombosis: molecular mechanisms and clinical evidence","volume":"24","author":"Cimmino","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179128_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009992","article-title":"Colchicine to prevent periprocedural myocardial injury in percutaneous coronary intervention: the COPE-PCI pilot trial","volume":"14","author":"Cole","year":"2021","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ejphar.2026.179128_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1098429","article-title":"COlchicine to prevent PeriprocEdural myocardial injury in percutaneous coronary intervention (COPE-PCI): Coronary microvascular physiology pilot substudy","volume":"2022","author":"Cole","year":"2022","journal-title":"J. Intervent. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.carrev.2021.09.006","article-title":"COlchicine to prevent PeriprocEdural myocardial injury in percutaneous coronary intervention (COPE-PCI): a descriptive cytokine pilot sub-study","volume":"39","author":"Cole","year":"2022","journal-title":"Cardiovasc. Revascularization Med.: Incl. Mol. Interv."},{"key":"10.1016\/j.ejphar.2026.179128_bib24","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":"Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout","volume":"39","author":"Crittenden","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejphar.2026.179128_bib25","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2026.179128_bib26","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/eurheartj\/ehaf210","article-title":"Colchicine for secondary prevention of vascular events: a meta-analysis of trials","volume":"46","author":"d'Entremont","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2026.179128_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.atherosclerosis.2016.02.010","article-title":"Association between cholesterol crystals and culprit lesion vulnerability in patients with acute coronary syndrome: an optical coherence tomography study","volume":"247","author":"Dai","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2026.179128_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.carrev.2022.06.017","article-title":"Colchicine and quality of life in patients with acute coronary syndromes: results from the COPS randomized trial","volume":"44","author":"Dawson","year":"2022","journal-title":"Cardiovasc. Revascularization Med.: Incl. Mol. Interv."},{"key":"10.1016\/j.ejphar.2026.179128_bib29","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","article-title":"Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study","volume":"132","author":"Deftereos","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179128_bib30","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jacc.2013.01.055","article-title":"Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients","volume":"61","author":"Deftereos","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.676771","article-title":"Efficacy and safety of colchicine in post-acute myocardial infarction patients: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Diaz-Arocutipa","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2026.179128_bib32","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.179128_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ehjqcco\/qcae021","article-title":"Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in the Netherlands","volume":"11","author":"Fiolet","year":"2025","journal-title":"Eur. Heart J. Qual. Care Clin. Outcome."},{"key":"10.1016\/j.ejphar.2026.179128_bib34","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0002-9149(99)80334-8","article-title":"Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty","volume":"76","author":"Freed","year":"1995","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajem.2021.02.039","article-title":"Colchicine administration for percutaneous coronary intervention: a meta-analysis of randomized controlled trials","volume":"46","author":"Fu","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ejphar.2026.179128_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2019.02.009","article-title":"Incidence, factors, and clinical significance of cholesterol crystals in coronary plaque: an optical coherence tomography study","volume":"283","author":"Fujiyoshi","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2026.179128_bib37","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/ar4250","article-title":"Modulation of monosodium urate crystal-induced responses in neutrophils by the myeloid inhibitory C-type lectin-like receptor: potential therapeutic implications","volume":"15","author":"Gagn\u00e9","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2026.179128_bib38","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s10787-021-00865-0","article-title":"Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial","volume":"29","author":"Gholoobi","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2026.179128_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40264-022-01265-1","article-title":"Colchicine drug interaction errors and misunderstandings: recommendations for improved evidence-based management","volume":"46","author":"Hansten","year":"2023","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejphar.2026.179128_bib40","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.hlc.2023.04.300","article-title":"The effects of statins on cardiovascular and inflammatory biomarkers in primary prevention: a systematic review and meta-analysis","volume":"32","author":"He","year":"2023","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.ejphar.2026.179128_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2019.06.003","article-title":"The low dose colchicine after myocardial infarction (LoDoCo-MI) study: a pilot randomized placebo controlled trial of colchicine following acute myocardial infarction","volume":"215","author":"Hennessy","year":"2019","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2026.179128_bib42","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/biomedicines12071467","article-title":"Decoding the role of CYP450 enzymes in metabolism and disease: a comprehensive review","volume":"12","author":"Hossam Abdelmonem","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2026.179128_bib43","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/FJC.0000000000001317","article-title":"Preprocedural colchicine in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a randomized controlled trial (PodCAST-PCI)","volume":"80","author":"Hosseini","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179128_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176297","article-title":"Colchicine ameliorates short-term abdominal aortic aneurysms by inhibiting the expression of NLRP3 inflammasome components in mice","volume":"964","author":"Hu","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179128_bib45","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/eurheartj\/ehab221","article-title":"Colchicine and the heart","volume":"42","author":"Imazio","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2026.179128_bib46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179128_bib47","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/ATVBAHA.124.322252","article-title":"Colchicine inhibits smooth muscle cell phenotypic switch and aortic dissection in mice-brief report","volume":"45","author":"Jiang","year":"2025","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.179128_bib48","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179128_bib49","first-page":"11","article-title":"Role of colchicine in reducing reperfusion injury in STEMI patients who undergo primary percutaneous coronary intervention: a randomized clinical trial","volume":"57","author":"Karim","year":"2025","journal-title":"Acta Med. Indones."},{"key":"10.1016\/j.ejphar.2026.179128_bib50","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood.V83.9.2451.2451","article-title":"P-glycoprotein expression and function in circulating blood cells from normal volunteers","volume":"83","author":"Klimecki","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2026.179128_bib51","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021198","article-title":"Colchicine in patients with coronary artery disease: a systematic review and meta\u2010analysis of randomized trials","volume":"10","author":"Kofler","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2026.179128_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.arcmed.2015.01.004","article-title":"Colchicine reduces restenosis after balloon angioplasty treatment for in-stent restenosis","volume":"46","author":"Kong","year":"2015","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ejphar.2026.179128_bib53","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s40261-021-01056-z","article-title":"Colchicine in patients with coronary artery disease with or without diabetes mellitus: a meta-analysis of randomized clinical trials","volume":"41","author":"Kuzemczak","year":"2021","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ejphar.2026.179128_bib54","first-page":"9","article-title":"Prevalence of ischemic heart disease in patients with familial mediterranean fever","volume":"3","author":"Langevitz","year":"2001","journal-title":"Isr. Med. Assoc. J.: Isr. Med. Assoc. J."},{"key":"10.1016\/j.ejphar.2026.179128_bib55","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jcin.2023.05.035","article-title":"P2Y12 inhibitor monotherapy combined with colchicine following PCI in ACS patients: the MACT pilot study","volume":"16","author":"Lee","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ejphar.2026.179128_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12872-023-03697-8","article-title":"Colchicine ameliorates myocardial injury induced by coronary microembolization through suppressing pyroptosis via the AMPK\/SIRT1\/NLRP3 signaling pathway","volume":"24","author":"Li","year":"2024","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ejphar.2026.179128_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10557-022-07326-y","article-title":"Colchicine inhibits NETs and alleviates cardiac remodeling after acute myocardial infarction","volume":"38","author":"Li","year":"2024","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2026.179128_bib58","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2017.12.027","article-title":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","volume":"269","author":"Mart\u00ednez","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2026.179128_bib59","first-page":"107","article-title":"Effect of trifluoperazine and colchicine on smooth muscle cellular proliferative and secretory activity induced by hypercholesterolemic medium in vitro","volume":"21","author":"Mehta","year":"1990","journal-title":"Biochem. Int."},{"key":"10.1016\/j.ejphar.2026.179128_bib60","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of colchicine on myocardial injury in acute myocardial infarction","volume":"144","author":"Mewton","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179128_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.898690","article-title":"Colchicine impacts leukocyte trafficking in atherosclerosis and reduces vascular inflammation","volume":"13","author":"Meyer-Lindemann","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.179128_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.898690","article-title":"Colchicine impacts leukocyte trafficking in atherosclerosis and reduces vascular inflammation","volume":"13","author":"Meyer-Lindemann","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.179128_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1244529","article-title":"Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial","volume":"10","author":"Mohammadnia","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2026.179128_bib64","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.jacc.2025.08.025","article-title":"Colchicine and longitudinal dynamics of clonal hematopoiesis: an exploratory substudy of the LoDoCo2 trial","volume":"86","author":"Mohammadnia","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib65","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacc.2023.05.055","article-title":"Low-dose colchicine for secondary prevention of coronary artery disease","volume":"82","author":"Nelson","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib66","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/eurheartj\/ehae208","article-title":"Low-dose colchicine for atherosclerosis: Long-term safety","volume":"45","author":"Nidorf","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2026.179128_bib67","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib68","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179128_bib69","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jbspin.2006.03.006","article-title":"Colchicine today","volume":"73","author":"Niel","year":"2006","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.ejphar.2026.179128_bib70","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/0735-1097(92)90624-V","article-title":"Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty","volume":"19","author":"O'Keefe","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib71","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2021.06.037","article-title":"Colchicine in patients with chronic coronary disease in relation to prior acute coronary syndrome","volume":"78","author":"Opstal","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib72","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.120.050560","article-title":"Colchicine attenuates inflammation beyond the inflammasome in chronic coronary artery disease: a LoDoCo2 proteomic substudy","volume":"142","author":"Opstal","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179128_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2022.12.026","article-title":"Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial","volume":"372","author":"Opstal","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib74","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/CIRCULATIONAHA.121.058233","article-title":"Long-term efficacy of colchicine in patients with chronic coronary disease: insights from LoDoCo2","volume":"145","author":"Opstal","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179128_bib75","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00296-013-2681-8","article-title":"Evaluation of circulating endothelial biomarkers in familial mediterranean fever","volume":"33","author":"Pamuk","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.ejphar.2026.179128_bib76","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00011-025-02058-9","article-title":"Clinical outcomes of anti-inflammatory therapies inhibiting the NLRP3\/IL-1\u03b2\/IL-6\/CRP pathway in coronary artery disease patients: a systemic review and meta-analysis of 37,056 individuals from 32 randomized trials","volume":"74","author":"Pan","year":"2025","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2026.179128_bib77","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jamacardio.2025.3469","article-title":"Clonal hematopoiesis-fuel to inflame the heart","volume":"10","author":"Pascual-Figal","year":"2025","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1104744","article-title":"Perspective: Collagen induced platelet activation via the GPVI receptor as a primary target of colchicine in cardiovascular disease","volume":"9","author":"Pennings","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2026.179128_bib79","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cvr\/cvae191","article-title":"Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction","volume":"121","author":"Psaltis","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.179128_bib80","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179128_bib81","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8317011","article-title":"Effect of treatment with colchicine after acute coronary syndrome on major cardiovascular events: a systematic review and meta-analysis of clinical trials","volume":"2022","author":"Razavi","year":"2022","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ejphar.2026.179128_bib82","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1055\/s-0038-1636915","article-title":"Procoagulant effects of low-level platelet activation and its inhibition by colchicine","volume":"47","author":"Reddel","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2026.179128_bib83","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179128_bib84","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjmed.2021.07.025","article-title":"Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease","volume":"135","author":"Robinson","year":"2022","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2026.179128_bib85","doi-asserted-by":"crossref","DOI":"10.1007\/BF00194404","article-title":"Pharmacokinetics and absolute bioavailability of colchicine after i. v. and oral administration in healthy human volunteers and elderly subjects","volume":"46","author":"Rochdi","year":"1994","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179128_bib86","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib87","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2337\/dc23-1825","article-title":"Low-dose colchicine in patients with type 2 diabetes and recent myocardial infarction in the colchicine cardiovascular outcomes trial (COLCOT)","volume":"47","author":"Roubille","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2026.179128_bib88","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejphar.2026.179128_bib89","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/eurheartj\/ehaf174","article-title":"Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis","volume":"46","author":"Samuel","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2026.179128_bib90","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/ehjqcco\/qcaa045","article-title":"Cost-effectiveness of low-dose colchicine after myocardial infarction in the colchicine cardiovascular outcomes trial (COLCOT)","volume":"7","author":"Samuel","year":"2021","journal-title":"Eur. Heart J. Qual. Care Clin. Outcome."},{"key":"10.1016\/j.ejphar.2026.179128_bib91","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1007\/s10787-024-01556-2","article-title":"Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications","volume":"32","author":"Satheesan","year":"2024","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2026.179128_bib92","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201469R","article-title":"Colchicine exerts anti\u2010atherosclerotic and -plaque\u2010stabilizing effects targeting foam cell formation","volume":"37","author":"Schwarz","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2026.179128_bib93","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008717","article-title":"Effects of acute colchicine administration prior to percutaneous coronary intervention: COLCHICINE-PCI randomized trial","volume":"13","author":"Shah","year":"2020","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ejphar.2026.179128_bib94","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.amjcard.2023.07.029","article-title":"Major adverse cardiovascular events after colchicine administration before percutaneous coronary intervention: Follow-up of the colchicine-PCI trial","volume":"204","author":"Shah","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib95","first-page":"1722","article-title":"Colchicine use and incident coronary artery disease in Male patients with gout","volume":"36","author":"Shah","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib96","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s40744-025-00772-8","article-title":"Prophylaxis of gout flares in patients with renal impairment: dosing adjustments with colchicine oral solution informed by a pharmacokinetic model","volume":"12","author":"Shah","year":"2025","journal-title":"Rheumatol. Ther."},{"key":"10.1016\/j.ejphar.2026.179128_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133045","article-title":"Colchicine for secondary prevention in patients with acute coronary syndrome: a systematic review and meta-analysis","volume":"425","author":"Shaikh","year":"2025","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib98","article-title":"Risk of coronary artery disease in patients with gout on treatment with colchicine: a systematic review and meta-analysis","volume":"45","author":"Siddiqui","year":"2023","journal-title":"IJC Heart Vasc."},{"key":"10.1016\/j.ejphar.2026.179128_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.013","article-title":"Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy","volume":"149","author":"Silva","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.179128_bib100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2021.08.005","article-title":"Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: a LoDoCo2 biomarker substudy","volume":"334","author":"Silvis","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2026.179128_bib101","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/rheumatology\/kex453","article-title":"Update on colchicine, 2017","volume":"57","author":"Slobodnick","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejphar.2026.179128_bib102","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/annrheumdis-2015-207984","article-title":"Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with medicare claims","volume":"75","author":"Solomon","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2026.179128_bib103","doi-asserted-by":"crossref","DOI":"10.1007\/s10557-023-07528-y","article-title":"Colchicine attenuates microvascular obstruction after myocardial ischemia-reperfusion injury by inhibiting the proliferation of neutrophil in bone marrow","author":"Tan","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2026.179128_bib104","author":"Tardif"},{"key":"10.1016\/j.ejphar.2026.179128_bib105","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179128_bib106","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2008.08.006","article-title":"Colchicine update: 2008","volume":"38","author":"Terkeltaub","year":"2009","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2026.179128_bib107","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1161\/CIRCULATIONAHA.121.054610","article-title":"Colchicine in patients with acute coronary syndrome: Two-year follow-up of the australian COPS randomized clinical trial","volume":"144","author":"Tong","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179128_bib108","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the australian COPS randomized clinical trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179128_bib109","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3390\/cells10061391","article-title":"Inflammation during percutaneous coronary intervention-prognostic value, mechanisms and therapeutic targets","volume":"10","author":"Tucker","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179128_bib110","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1345\/aph.1H064","article-title":"Rhabdomyolysis in a patient treated with colchicine and atorvastatin","volume":"40","author":"Tufan","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179128_bib111","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40256-021-00485-7","article-title":"Safety and efficacy of colchicine in patients with stable CAD and ACS: a systematic review and meta-analysis","volume":"21","author":"Ullah","year":"2021","journal-title":"Am. J. Cardiovasc. Drugs: Drug. Device. Other Interv."},{"key":"10.1016\/j.ejphar.2026.179128_bib112","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study","volume":"11","author":"Vaidya","year":"2018","journal-title":"JACC, Cardiovasc. Imaging"},{"key":"10.1016\/j.ejphar.2026.179128_bib113","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American heart association\/American college of cardiology joint committee on clinical practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179128_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119239","article-title":"Experimental evidence on colchicine's mode of action in human carotid artery plaques","volume":"406","author":"Von Ehr","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2026.179128_bib115","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2026.179128_bib116","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/annrheumdis-2014-206074","article-title":"AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages","volume":"75","author":"Wang","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2026.179128_bib117","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s44161-026-00807-5","article-title":"Mechanisms and therapeutic potential of colchicine in atherosclerotic cardiovascular disease","volume":"5","author":"Xia","year":"2026","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.179128_bib118","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9173530","article-title":"Colchicine alleviates cholesterol crystal-induced endothelial cell pyroptosis through activating AMPK\/SIRT1 pathway","volume":"2020","author":"Yang","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2026.179128_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102878","article-title":"The effect of colchicine on myocardial infarction: an updated systematic review and meta-analysis of randomized controlled trials","volume":"50","author":"Younas","year":"2025","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179128_bib120","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.124.069808","article-title":"Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial","volume":"150","author":"Yu","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179128_bib121","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/FJC.0000000000001509","article-title":"Different anti-inflammatory drugs on high-sensitivity C-reactive protein in patients after percutaneous coronary intervention: a pilot randomized clinical trial","volume":"83","author":"Yu","year":"2024","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179128_bib122","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41401-024-01438-x","article-title":"Colchicine reduces neointima formation and VSMC phenotype transition by modulating SRF-MYOCD activation and autophagy","volume":"46","author":"Zhang","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2026.179128_bib123","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1038\/s41401-021-00835-w","article-title":"Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review","volume":"43","author":"Zhang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2026.179128_bib124","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12950-023-00366-7","article-title":"Colchicine prevents oxidative stress-induced endothelial cell senescence via blocking NF-\u03baB and MAPKs: implications in vascular diseases","volume":"20","author":"Zhou","year":"2023","journal-title":"J. Inflamm."},{"key":"10.1016\/j.ejphar.2026.179128_bib125","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1093\/eurheartj\/ehae546","article-title":"Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis","volume":"45","author":"Zuriaga","year":"2024","journal-title":"Eur. Heart J."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:34:38Z","timestamp":1786235678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926006102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":125,"alternative-id":["S0014299926006102"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179128","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research advances of colchicine in anti-inflammatory treatment for coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179128"}}